| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2025―Apr―02 |
B Cell Dynamics and Transitional B Cells in Long COVID |
Zoia R. Korobova, Natalia A. Arsentieva, Natalia E. Liubimova, Oleg K. Batsunov, Anastasia A. Butenko, Albina E. Kokoeva, Natalia G. Kucherenko, Victor A. Kashchenko, Ekaterina V. Boeva, Anna O. Norka, Anastasia A. Knizhnikova, Vadim V. Rassokhin, Nikolay A. Belyakov, Areg A. Totolian |
| 2 |
[GO] |
2025―Mrz―17 |
Structure-Based Identification of SARS-CoV-2 nsp10-16 Methyltransferase Inhibitors Using Molecular Dynamics Insights |
Ahmad M. Alharbi |
| 3 |
[GO] |
2025―Mrz―12 |
Anti-Infective Screening of Selected Nine Cannabinoids Against Clostridium perfringens and Influenza A (H5N1) Neuraminidases, and SARS-CoV-2 Main Protease and Spike Protein Interactions |
Thanet Pitakbut, Oliver Kayser |
| 4 |
[GO] |
2025―Mrz―11 |
The Legacy of COVID-19 in Breast Milk: The Association of Elevated Anti-Inflammatory and Antimicrobial Proteins with Vaccination or Infection |
Felicia Trofin, Petru Cianga, Daniela Constantinescu, Luminița Smaranda Iancu, Roxana Irina Iancu, Diana Păduraru, Eduard Vasile Nastase, Elena Roxana Buzilă, Cătălina Luncă, Corina Maria Cianga, Olivia Simona Dorneanu |
| 5 |
[GO] |
2025―Feb―28 |
A Pilot Study on the Role of TRAFs in the Development of SARS-CoV-2 Infection Before and After Immunization with AstraZeneca Chadox1 in Mice |
Mounia Ammara, Inass Samiry, Younes Zaid, Mounia Oudghiri, Abdallah Naya |
| 6 |
[GO] |
2024―Nov―12 |
Computational Insights into Acrylamide Fragment Inhibition of SARS-CoV-2 Main Protease |
Ping Chen, Liyuan Wu, Bo Qin, Haodong Yao, Deting Xu, Sheng Cui, Lina Zhao |
| 7 |
[GO] |
2024―Nov―06 |
Benchmark Investigation of SARS-CoV-2 Mutants’ Immune Escape with 2B04 Murine Antibody: A Step Towards Unraveling a Larger Picture |
Karina Kapusta, Allyson McGowan, Santanu Banerjee, Jing Wang, Wojciech Kolodziejczyk, Jerzy Leszczynski |
| 8 |
[GO] |
2024―Okt―23 |
SARS-CoV-2 and Environmental Changes: The Perfect Storm |
Mario Caldarelli, Pierluigi Rio, Vincenzo Giambra, Ivana Palucci, Antonio Gasbarrini, Giovanni Gambassi, Rossella Cianci |
| 9 |
[GO] |
2024―Okt―22 |
Impact of Hyponatremia and ADH Secretion in MIS-C and COVID-19: An Integrative Approach of Prognostic and Diagnostic Markers |
Diana-Andreea Ciortea, Carmen Loredana Petrea (Cliveți), Sorin Ion Berbece, Silvia Fotea, Iolanda Cristina Vivisenco, Gabriela Gurău, Mădălina Nicoleta Matei, Aurel Nechita |
| 10 |
[GO] |
2024―Okt―02 |
Enhanced RBD-Specific Antibody Responses and SARS-CoV-2-Relevant T-Cell Activity in Healthcare Workers Following Booster Vaccination |
Lina Souan, Hikmat Abdel-Razeq, Maher A. Sughayer |
| 11 |
[GO] |
2024―Aug―15 |
Dysregulated Inflammatory Cytokine Levels May Be Useful Markers in a Better Up-Dated Management of COVID-19 |
Marco Iuliano, Roberta Maria Mongiovì, Alberico Parente, Blerta Kertusha, Anna Carraro, Raffaella Marocco, Giulia Mancarella, Cosmo Del Borgo, Laura Fondaco, Lorenzo Grimaldi, Maria Dorrucci, Miriam Lichtner, Giorgio Mangino, Giovanna Romeo |
| 12 |
[GO] |
2024―Aug―10 |
A New Case of Paediatric Systemic Lupus Erythematosus with Onset after SARS-CoV-2 and Epstein-Barr Infection-A Case Report and Literature Review |
Carmen Loredana Petrea (Cliveți), Diana-Andreea Ciortea, Magdalena Miulescu, Iuliana-Laura Candussi, Sergiu Ioachim Chirila, Gabriela Isabela Verga (Răuță), Simona-Elena Bergheș, Mihai Ciprian Râșcu, Sorin Ion Berbece |
| 13 |
[GO] |
2024―Aug―06 |
Are COVID-19 Polymorphisms in ACE and ACE2 Prognosis Predictors? |
Fabiana Amaral Guarienti, Fernando Antônio Costa Xavier, Mateus Duarte Ferraz, Fernanda Wagner, Daniel Rodrigo Marinowic, Jaderson Costa da Costa, Denise Cantarelli Machado |
| 14 |
[GO] |
2024―Jul―10 |
Preliminary Study on the Restoration of the Phospholipid Profile in Serum from Patients with COVID-19 by Treatment with Vitamin E |
María Elena Soto, Linaloe Manzano-Pech, Verónica Guarner-Lans, Adrían Palacios-Chavarría, Rafael Ricardo Valdez-Vázquez, Raúl Martínez-Memije, Mohammed El-Hafidi, Félix Leao Rodríguez-Fierros, Israel Pérez-Torres |
| 15 |
[GO] |
2024―Jun―28 |
Potential Protective Factors for Allergic Rhinitis Patients Infected with COVID-19 |
Jiaoyue Dong, Dingyuan Su, Binbin Zhao, Jiayang Han, Mengjie Tu, Kaifeng Zhang, Fengling Wang, Yang An |
| 16 |
[GO] |
2024―Jun―21 |
MAFLD Pandemic: Updates in Pharmacotherapeutic Approach Development |
Farah Khaznadar, Omar Khaznadar, Ana Petrovic, Marija Hefer, Fabian Gjoni, Stefan Gjoni, Justinija Steiner, Martina Smolic, Kristina Bojanic |
| 17 |
[GO] |
2024―Jun―10 |
Genomic Evolution Strategy in SARS-CoV-2 Lineage B: Coevolution of Cis Elements |
Yahaira de J. Tamayo-Ordóñez, Ninfa M. Rosas-García, Francisco A. Tamayo-Ordoñez, Benjamín A. Ayil-Gutiérrez, Juan M. Bello-López, Gerardo de J. Sosa-Santillán, Erika Acosta-Cruz, Francisco Anguebes-Franseschi, Siprian Damas-Damas, Angel V. Domínguez-May, Atl Victor Córdova-Quiroz, María Concepción Tamayo-Ordóñez |
| 18 |
[GO] |
2024―Mai―10 |
SARS-CoV-2-Induced Type I Interferon Signaling Dysregulation in Olfactory Networks Implications for Alzheimer’s Disease |
George D. Vavougios, Theodoros Mavridis, Triantafyllos Doskas, Olga Papaggeli, Pelagia Foka, Georgios Hadjigeorgiou |
| 19 |
[GO] |
2024―Mai―06 |
Insights into the Activation of Unfolded Protein Response Mechanism during Coronavirus Infection |
Panagiotis Keramidas, Maria Pitou, Eleni Papachristou, Theodora Choli-Papadopoulou |
| 20 |
[GO] |
2024―Mai―03 |
Angiopoietins as Predictor Indexes in COVID-19 Patients in Delta and Omicron Waves |
Panagiota Tsiatsiou, Kyriakos Kouirouxis, Vasiliki Tsaireli, Antonia Lanta, Angeliki Kassomenaki, Maria Papaioannou, Efthymia Protonotariou, Lemonia Skoura |
| 21 |
[GO] |
2024―Apr―18 |
CCN1-Mediated Signaling in Placental Villous Tissues after SARS-CoV-2 Infection in Term Pregnant Women: Implications for Dysregulated Angiogenesis |
Yuyang Ma, Liyan Duan, Beatrix Reisch, Rainer Kimmig, Antonella Iannaccone, Alexandra Gellhaus |
| 22 |
[GO] |
2024―Feb―29 |
COVID-19 Associated Cardiovascular Disease-Risks, Prevention and Management: Heart at Risk Due to COVID-19 |
Andrew Kemerley, Abhishek Gupta, Mahesh Thirunavukkarasu, Monica Maloney, Sean Burgwardt, Nilanjana Maulik |
| 23 |
[GO] |
2024―Jan―25 |
Disruption of the Functional Activity of Neutrophil Granulocytes as a Risk Factor for the Development of Lung Damage in Pregnant Women with COVID-19 |
Irina Anatolyevna Andrievskaya, Egor Mikhailovich Ustinov, Karen Sargisovich Lyazgian, Nataliya Alexandrovna Ishutina, Inna Victorovna Dovzhikova |
| 24 |
[GO] |
2024―Jan―24 |
An Expeditious Neutralization Assay for Porcine Reproductive and Respiratory Syndrome Virus Based on a Recombinant Virus Expressing Green Fluorescent Protein |
Juan Wang, Jiecong Yan, Shuaiyong Wang, Ronglin Chen, Yanru Xing, Qingyan Liu, Shuolei Gao, Yuxiang Zhu, Jiannan Li, Yanjun Zhou, Tongling Shan, Wu Tong, Hao Zheng, Ning Kong, Yifeng Jiang, Changlong Liu, Guangzhi Tong, Hai Yu |
| 25 |
[GO] |
2024―Jan―02 |
Single-Cell RNA Sequencing Reveals Alterations in Patient Immune Cells with Pulmonary Long COVID-19 Complications |
Kristīne Vaivode, Rihards Saksis, Helēna Daiga Litvina, Helvijs Niedra, Marta Līva Spriņģe, Una Krūmiņa, Jānis Kloviņš, Vita Rovite |
| 26 |
[GO] |
2023―Dez―18 |
In Silico Analysis of SARS-CoV-2 Non-Structural Proteins Reveals an Interaction with the Host’s Heat Shock Proteins That May Contribute to Viral Replications and Development |
Mthembu Yamkela, Zingisa Sitobo, Xolani H. Makhoba |
| 27 |
[GO] |
2023―Sep―29 |
The Sphingolipid-Signaling Pathway as a Modulator of Infection by SARS-CoV-2 |
Simona Fenizia, Melania Gaggini, Cristina Vassalle |
| 28 |
[GO] |
2023―Sep―29 |
Identification of T-Cell Epitopes Using a Combined In-Silico and Experimental Approach in a Mouse Model for SARS-CoV-2 |
Noam Erez, Hagit Achdout, Yfat Yahalom-Ronen, Shimrit Adutler-Lieber, Liat Bar-On, Erez Bar-Haim, Boaz Politi, Einat B. Vitner, Hadas Tamir, Sharon Melamed, Nir Paran, Tomer Israely |
| 29 |
[GO] |
2023―Aug―28 |
Pathological Effects of SARS-CoV-2 Associated with Hematological Abnormalities |
Asif Mahmood, Shahid Mehmood, Wen Zhang |
| 30 |
[GO] |
2023―Jul―19 |
A Clinical Qualification Protocol Highlights Overlapping Genomic Influences and Neuro-Autonomic Mechanisms in Ehlers-Danlos and Long COVID-19 Syndromes |
Golder N. Wilson |
| 31 |
[GO] |
2023―Jul―14 |
Genome-Wide Mining of Selaginella moellendorffii for Hevein-like Lectins and Their Potential Molecular Mimicry with SARS-CoV-2 Spike Glycoprotein |
Ahmed Alsolami, Amina I. Dirar, Emadeldin Hassan E. Konozy, Makarim El-Fadil M. Osman, Mohanad A. Ibrahim, Khalid Farhan Alshammari, Fawwaz Alshammari, Meshari Alazmi, Kamaleldin B. Said |
| 32 |
[GO] |
2023―Jul―03 |
Exploring Key Biomarkers and Common Pathogenesis of Seven Digestive System Cancers and Their Correlation with COVID-19 |
Zuming Xiong, Yongjun Yang, Wenxin Li, Yirong Lin, Wei Huang, Sen Zhang |
| 33 |
[GO] |
2023―Mai―08 |
Cycle Threshold (Ct) Values of SARS-CoV-2 Detected with the GeneXpert® System and a Mutation Associated with Different Target Gene Failure |
Keita Yamashita, Terumi Taniguchi, Noriyasu Niizeki, Yuki Nagao, Akira Suzuki, Akihiro Toguchi, Shiori Takebayashi, Jinko Ishikawa, Osanori Nagura, Kazuki Furuhashi, Moriya Iwaizumi, Masato Maekawa |
| 34 |
[GO] |
2023―Apr―05 |
Host-Based Treatments for Severe COVID-19 |
Lucrezia Mondini, Francesco Salton, Liliana Trotta, Chiara Bozzi, Riccardo Pozzan, Mariangela Barbieri, Stefano Tavano, Selene Lerda, Michael Hughes, Marco Confalonieri, Paola Confalonieri, Barbara Ruaro |
| 35 |
[GO] |
2023―Apr―04 |
Liver Damage and COVID-19: At Least a “Two-Hit” Story in Systematic Review |
Michele Montori, Gialuca Svegliati Baroni, Pierangelo Santori, Catia Di Giampaolo, Francesca Ponziani, Ludovico Abenavoli, Emidio Scarpellini |
| 36 |
[GO] |
2023―Apr―04 |
Endogenous piRNAs Can Interact with the Omicron Variant of the SARS-CoV-2 Genome |
Aizhan Rakhmetullina, Aigul Akimniyazova, Togzhan Niyazova, Anna Pyrkova, Saltanat Kamenova, Aida Kondybayeva, Alma-Gul Ryskulova, Anatoliy Ivashchenko, Piotr Zielenkiewicz |
| 37 |
[GO] |
2023―Mrz―16 |
Immunohistochemical Analysis of Spermatogenesis in Patients with SARS-CoV-2 Invasion in Different Age Groups |
Grigory A. Demyashkin, Evgeniya Kogan, Tatiana Demura, Dmitry Boldyrev, Matvey Vadyukhin, Vladimir Schekin, Peter Shegay, Andrey Kaprin |
| 38 |
[GO] |
2023―Mrz―01 |
Biomarker Profiles Associated with COVID-19 Severity and Mortality |
Silvia Sánchez-Díez, Carlos Gómez-Ollés, María-Jesús Cruz, Miquel de Homdedeu, David Espejo, Jaume Ferrer, Oriol Roca, Andrés Pacheco, Xavier Muñoz |
| 39 |
[GO] |
2023―Feb―10 |
Proof-of-Concept Analysis of B Cell Receptor Repertoire in COVID-19 Patients Undergoing ECMO by Single-Cell V(D)J and Gene Expression Sequencing |
Alessia Gallo, Nicola Cuscino, Claudia Carcione, Rosalia Busà, Pier Giulio Conaldi, Matteo Bulati |
| 40 |
[GO] |
2023―Feb―08 |
Synthesis, Molecular Docking, and Dynamic Simulation Targeting Main Protease (Mpro) of New, Thiazole Cl믭 Pyridine Scaffolds as Potential COVID-19 Inhibitors |
Adel Alghamdi, Amr S. Abouzied, Abdulwahab Alamri, Sirajudheen Anwar, Mukhtar Ansari, Ibrahim Khadra, Yasser H. Zaki, Sobhi M. Gomha |
| 41 |
[GO] |
2023―Jan―20 |
Clinical Investigation of Leukocyte DNA Damage in COVID-19 Patients |
Hasan Doğan, Aslı Kara, Erdem Çankaya, Eda Balkan, Muhammet Ali Gürbüz, Murat Kızılkaya, Merve Aykaç |
| 42 |
[GO] |
2023―Jan―12 |
In Vitro Antiviral Evaluations of Coldmix®: An Essential Oil Blend against SARS-CoV-2 |
Kemal Hüsnü Can Başer, Ayşe Esra Karadağ, Sevde Nur Biltekin, Murat Ertürk, Fatih Demirci |
| 43 |
[GO] |
2023―Jan―05 |
A Clinical Update on SARS-CoV-2: Pathology and Development of Potential Inhibitors |
Desh Deepak Singh, Ihn Han, Eun-Ha Choi, Dharmendra Kumar Yadav |
| 44 |
[GO] |
2023―Jan―02 |
Severe Acute Respiratory Syndrome Coronavirus-2 Delta Variant Study In Vitro and Vivo |
Hranush Avagyan, Sona Hakobyan, Arpine Poghosyan, Lina Hakobyan, Liana Abroyan, Elena Karalova, Aida Avetisyan, Mariam Sargsyan, Bagrat Baghdasaryan, Nane Bayramyan, Diana Avetyan, Zaven Karalyan |
| 45 |
[GO] |
2023―Jan―02 |
Increased mTOR Signaling and Impaired Autophagic Flux Are Hallmarks of SARS-CoV-2 Infection |
Érika Pereira Zambalde, Thomaz Luscher Dias, Grazielle Celeste Maktura, Mariene R. Amorim, Bianca Brenha, Luana Nunes Santos, Lucas Buscaratti, João Gabriel de Angeli Elston, Mariana Camargo Silva Mancini, Isadora Carolina Betim Pavan, Daniel A. Toledo-Teixeira, Karina Bispo-dos-Santos, Pierina L. Parise, Ana Paula Morelli, Luiz Guilherme Salvino da Silva, Ícaro Maia Santos de Castro, Tatiana D. Saccon, Marcelo A. Mori, Fabiana Granja, Helder I. Nakaya, Jose Luiz Proenca-Modena, Henrique Marques-Souza, Fernando Moreira Simabuco |
| 46 |
[GO] |
2022―Dez―21 |
Autoimmunity and Immunodeficiency in Severe SARS-CoV-2 Infection and Prolonged COVID-19 |
Jenny Valentina Garmendia, Alexis Hipólito García, Claudia Valentina De Sanctis, Marián Hajdúch, Juan Bautista De Sanctis |
| 47 |
[GO] |
2022―Dez―21 |
The Potential of Stilbene Compounds to Inhibit Mpro Protease as a Natural Treatment Strategy for Coronavirus Disease-2019 |
Ayesha Naseem, Fatima Rasool, Abrar Ahmed, Wayne G. Carter |
| 48 |
[GO] |
2022―Nov―28 |
Pathological Evidence for Residual SARS-CoV-2 in the Micrometastatic Niche of a Patient with Ovarian Cancer |
Takuma Hayashi, Kenji Sano, Nobuo Yaegashi, Ikuo Konishi |
| 49 |
[GO] |
2022―Nov―16 |
Review of Developments in Combating COVID-19 by Vaccines, Inhibitors, Radiations, and Nonthermal Plasma |
Ihn Han, Sohail Mumtaz, Sekar Ashokkumar, Dharmendra Kumar Yadav, Eun Ha Choi |
| 50 |
[GO] |
2022―Okt―30 |
Increased Levels of Autoantibodies against ROS-Modified Proteins in Depressed Individuals with Decrease in Antibodies against SARS-CoV-2 Antigen (S1-RBD) |
Subuhi Sherwani, Mohamed Raafat, Saravanan Rajendrasozhan, Mahvish Khan, Mohd Saleem, Qayyum Husain, Saif Khan, Noor Alam, Mohd Wajid Ali Khan |
| 51 |
[GO] |
2022―Okt―20 |
Targeting Natural Plant Metabolites for Hunting SARS-CoV-2 Omicron BA.1 Variant Inhibitors: Extraction, Molecular Docking, Molecular Dynamics, and Physicochemical Properties Study |
Heba Ali Hassan, Ahmed R. Hassan, Eslam A. R. Mohamed, Ahmad Al-Khdhairawi, Hala E. Taha, Hanan M. El-Tantawy, Iman A. M. Abdel-Rahman, Ali E. Raslan, Khaled S. Allemailem, Ahmad Almatroudi, Faris Alrumaihi, Maha A. Alshiekheid, Hafiz Muzzammel Rehman, Mahmoud M. Abdelhamid, Islam M. Abdel-Rahman, Ahmed E. Allam |
| 52 |
[GO] |
2022―Okt―12 |
Era of Molecular Diagnostics Techniques before and after the COVID-19 Pandemic |
Ahmad M. Alamri, Faris A. Alkhilaiwi, Najeeb Ullah Khan |
| 53 |
[GO] |
2022―Okt―11 |
Cytokine Patterns in COVID-19 Patients: Which Cytokines Predict Mortality and Which Protect Against? |
Maamoun Basheer, Elias Saad, Majd Kananeh, Layyous Asad, Osama Khayat, Anan Badarne, Zaki Abdo, Nada Arraf, Faris Milhem, Tamara Bassal, Mariana Boulos, Nimer Assy |
| 54 |
[GO] |
2022―Sep―30 |
Synthesis and In Silico Study of Some New bis-[1,3,4]thiadiazolimines and bis-Thiazolimines as Potential Inhibitors for SARS-CoV-2 Main Protease |
Sobhi M. Gomha, Sayed M. Riyadh, Magda H. Abdellattif, Tariq Z. Abolibda, Hassan M. Abdel-aziz, AbdElAziz. A. Nayl, Alaa M. Elgohary, Abdo A. Elfiky |
| 55 |
[GO] |
2022―Jul―22 |
COVID-19 Survivor Patients Carrying the Rs35705950 Risk Allele in MUC5B Have Higher Plasma Levels of Mucin 5B |
Salvador García-Carmona, Ramcés Falfán-Valencia, Abigail Verónica-Aguilar, Ivette Buendía-Roldán, Leslie Chávez-Galán, Rafael de Jesús Hernández-Zenteno, Alfonso Martínez-Morales, Ingrid Fricke-Galindo, Jesús Alanis-Ponce, Daniela Valencia-Pérez Rea, Ilse Adriana Gutiérrez-Pérez, Oscar Zaragoza-García, Karol J. Nava-Quiroz, Angel Camarena, Mayra Mejía, Iris Paola Guzmán-Guzmán, Gloria Pérez-Rubio |
| 56 |
[GO] |
2022―Jul―04 |
Virtual Screening of Repurposed Drugs as Potential Spike Protein Inhibitors of Different SARS-CoV-2 Variants: Molecular Docking Study |
Ahmad F. Eweas, Hosam-Eldin H. Osman, Ibrahim A. Naguib, Mohammed A. S. Abourehab, Ahmed S. Abdel-Moneim |
| 57 |
[GO] |
2022―Jun―29 |
Targeted Genotyping of MIS-C Patients Reveals a Potential Alternative Pathway Mediated Complement Dysregulation during COVID-19 Infection |
Eleni Gavriilaki, Stefanos A. Tsiftsoglou, Tasoula Touloumenidou, Evangelia Farmaki, Paraskevi Panagopoulou, Elissavet Michailidou, Evaggelia-Evdoxia Koravou, Ioulia Mavrikou, Elias Iosifidis, Olga Tsiatsiou, Eleni Papadimitriou, Efimia Papadopoulou-Alataki, Penelope Georgia Papayanni, Christos Varelas, Styliani Kokkoris, Apostolia Papalexandri, Maria Fotoulaki, Assimina Galli-Tsinopoulou, Dimitrios Zafeiriou, Emmanuel Roilides, Ioanna Sakellari, Achilles Anagnostopoulos, Athanasios Tragiannidis |
| 58 |
[GO] |
2022―Jun―29 |
The Occluded Epitope Residing in Spike Receptor-Binding Motif Is Essential for Cross-Neutralization of SARS-CoV-2 Delta Variant |
Weeraya Thongkum, Kanyarat Thongheang, Chatchai Tayapiwatana |
| 59 |
[GO] |
2022―Mai―10 |
Investigating the Link between Alpha-1 Antitrypsin and Human Neutrophil Elastase in Bronchoalveolar Lavage Fluid of COVID-19 Patients |
Maura D’Amato, Valentina Vertui, Laura Pandolfi, Sara Bozzini, Tommaso Fossali, Riccardo Colombo, Anna Aliberti, Marco Fumagalli, Paolo Iadarola, Camilla Didò, Simona Viglio, Federica Meloni |
| 60 |
[GO] |
2022―Apr―20 |
Revealing Potential Bioactive Compounds and Mechanisms of Lithospermum erythrorhizon against COVID-19 via Network Pharmacology Study |
Ki-Kwang Oh, Md. Adnan |
| 61 |
[GO] |
2022―Apr―12 |
Comment on Aldén et al. Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line. Curr. Issues Mol. Biol. 2022, 44, 1115-1126 |
Hamid A. Merchant |
| 62 |
[GO] |
2022―Apr―08 |
Network Pharmacology Study to Elucidate the Key Targets of Underlying Antihistamines against COVID-19 |
Ki-Kwang Oh, Md. Adnan, Dong-Ha Cho |
| 63 |
[GO] |
2022―Feb―28 |
Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line |
Markus Aldén, Francisko Olofsson Falla, Daowei Yang, Mohammad Barghouth, Cheng Luan, Magnus Rasmussen, Yang De Marinis |
| 64 |
[GO] |
2022―Feb―07 |
Transcription of the Envelope Protein by 1-L Protein-RNA Recognition Code Leads to Genes/Proteins That Are Relevant to the SARS-CoV-2 Life Cycle and Pathogenesis |
Jozef Nahalka |
| 65 |
[GO] |
2022―Jan―11 |
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Mutational Pattern in the Fourth Pandemic Phase in Greece |
Panagiotis Halvatsiotis, Sofia Vassiliu, Panagiotis Koulouvaris, Kalliopi Chatzantonaki, Konstantinos Asonitis, Ekatherina Charvalos, Argyris Siatelis, Dimitra Houhoula |
| 66 |
[GO] |
2022―Jan―06 |
Possibility of SARS-CoV-2 Infection in the Metastatic Microenvironment of Cancer |
Takuma Hayashi, Kenji Sano, Ikuo Konishi |
| 67 |
[GO] |
2021―Dez―31 |
Alterations in B Cell and Follicular T-Helper Cell Subsets in Patients with Acute COVID-19 and COVID-19 Convalescents |
Igor V. Kudryavtsev, Natalia A. Arsentieva, Oleg K. Batsunov, Zoia R. Korobova, Irina V. Khamitova, Dmitrii V. Isakov, Raisa N. Kuznetsova, Artem A. Rubinstein, Oksana V. Stanevich, Aleksandra A. Lebedeva, Evgeny A. Vorobyov, Snejana V. Vorobyova, Alexander N. Kulikov, Maria A. Sharapova, Dmitrii E. Pevtcov, Areg A. Totolian |
| 68 |
[GO] |
2021―Dez―22 |
Protective Effect of Melatonin Administration against SARS-CoV-2 Infection: A Systematic Review |
Antonio Molina-Carballo, Rafael Palacios-López, Antonio Jerez-Calero, María Carmen Augustín-Morales, Ahmed Agil, Antonio Muñoz-Hoyos, Antonio Muñoz-Gallego |
| 69 |
[GO] |
2021―Nov―18 |
A Comparative Study between Spanish and British SARS-CoV-2 Variants |
Jose A. Jimenez Ruiz, Cecilia Lopez Ramirez, Jose Luis Lopez-Campos |
| 70 |
[GO] |
2021―Nov―08 |
Strategy to Develop and Evaluate a Multiplex RT-ddPCR in Response to SARS-CoV-2 Genomic Evolution |
Laura A. E. Van Poelvoorde, Mathieu Gand, Marie-Alice Fraiture, Sigrid C. J. De Keersmaecker, Bavo Verhaegen, Koenraad Van Hoorde, Ann Brigitte Cay, Nadège Balmelle, Philippe Herman, Nancy Roosens |
| 71 |
[GO] |
2021―Sep―23 |
A Potential Role of the CD47/SIRPalpha Axis in COVID-19 Pathogenesis |
Katie-May McLaughlin, Denisa Bojkova, Joshua D. Kandler, Marco Bechtel, Philipp Reus, Trang Le, Florian Rothweiler, Julian U. G. Wagner, Andreas Weigert, Sandra Ciesek, Mark N. Wass, Martin Michaelis, Jindrich Cinatl |
| 72 |
[GO] |
2021―Aug―02 |
Next-Generation Sequencing (NGS) in COVID-19: A Tool for SARS-CoV-2 Diagnosis, Monitoring New Strains and Phylodynamic Modeling in Molecular Epidemiology |
Goldin John, Nikhil Shri Sahajpal, Ashis K. Mondal, Sudha Ananth, Colin Williams, Alka Chaubey, Amyn M. Rojiani, Ravindra Kolhe |
| 73 |
[GO] |
2021―Jul―20 |
Coronavirus Disease 2019 (COVID-19) Diagnostic Tools: A Focus on Detection Technologies and Limitations |
Ahmad Qasem, Ameera M. Shaw, Erij Elkamel, Saleh A. Naser |
|
